2023-22672. National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting  

  • Start Preamble

    Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering.

    The meeting will be open to the public by videocast as indicated below. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should Start Printed Page 71004 notify the contact person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website ( https://videocast.nih.gov/​).

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering NACBIB, January 2024.

    Date: January 23, 2024.

    Open: 12:00 p.m. to 2:50 p.m.

    Agenda: Report from the Institute Director, Council Members and other Institute Staff.

    Place: National Institutes of Health, Democracy II, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).

    Closed: 3:00 p.m. to 4:00 p.m.

    Agenda: To review and evaluate grant applications and/or proposals.

    Place: National Institutes of Health, Democracy II, 6707 Democracy Boulevard, Bethesda, MD 20892.

    Contact Person: Kathy Salaita, Sc.D., Acting Associate Director for Research Administration, Office of Research Administration, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Bethesda, MD 20892, kathy.salaita@nih.gov.

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    Information is also available on the Institute's/Center's home page: https://www.nibib.nih.gov/​about-nibib/​advisory-council where an agenda and any additional information for the meeting will be posted when available.

    Start Signature

    Dated: October 10, 2023.

    Victoria E. Townsend,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2023–22672 Filed 10–12–23; 8:45 am]

    BILLING CODE 4140–01–P

Document Information

Published:
10/13/2023
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2023-22672
Dates:
January 23, 2024.
Pages:
71003-71004 (2 pages)
PDF File:
2023-22672.pdf